Prevalence of pulmonary embolism in patients with COVID-19, april - december 2020

Authors

  • Tatiana Suárez Poveda Hospital Universitario San Vicente Fundación. Medellín
  • Johan Sebastián Lopera Valle Universidad de Antioquia. Medellín
  • Vanesa Andrea Vasco Lopez Universidad de Antioquia. Medellín

DOI:

https://doi.org/10.53903/01212095.147

Keywords:

Coronavirus infections, Pulmonary embolism, Computed tomography angiography

Abstract

Introduction: Thrombotic events associated with COVID-19 infection contribute to higher morbidity and mortality of patients. The objective was to review the clinical and imaging characteristics of patients with suspected diagnosis of pulmonary embolism (PE) and COVID-19 infection, from April to December 2020. Methodology: Cross-Sectional observational study that included patients with a molecular diagnosis of SARS CoV-2 infection and chest computed tomography angiography (CT angiography) performed for suspected PE. Patients were divided into two groups (PE vs No PE). Qualitative variables were compared with each other with Pearson’s Chi2 test or Fisher’s exact test, and quantitative variables were analized with the Student’s T test or the Mann-Whitney U test. Results: 127 patients were included with a median age of 60 (IQR: 45-69) years, 68 (53.5%) were men and 23.6% (n = 30) presented PE. When comparing PE (n = 30) vs No PE (n = 97), the first group required more mechanical ventilation, extended days of hospitalization, higher mortality as well as higher levels of D-Dimer, all with statistically significant difference (p < 0.05). Conclusion: A quarter of patients with COVID-19 presented PE as a complication with high levels of D-dimer, a higher frequency of ventilatory assistance, more days of hospitalization and higher mortality.

Downloads

Download data is not yet available.

References

Cao Z, Li T, Liang L, Wang H, Wei F, Meng S, et al. Clinical characteristics of Coronavirus Disease 2019 patients in Beijing, China. PLoS One [Internet]. 2020;15(6):e0234764. http://dx.doi.org/10.1371/journal.pone.0234764

Zu ZY, Jiang MD, Xu PP, Chen W, Ni QQ, Lu GM, et al. Coronavirus disease 2019 (COVID-19): A perspective from China. Radiology [Internet]. 2020;296(2):E15-25. http://dx.doi.org/10.1148/radiol.2020200490

Poggiali E, Bastoni D, Ioannilli E, Vercelli A, Magnacavallo A. Deep vein thrombosis and pulmonary embolism: Two complications of COVID-19 pneumonia? Eur J Case Rep Intern Med [Internet]. 2020 [citado: 2022 mar 8];7(5):1. Disponible en: https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC7213837/

Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet [Internet]. 2020 [citado: 2022 mar. 8];395(10223):497-506. Disponible en: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)30183-5/fulltext

Tamburello A, Bruno G, Marando M. COVID-19 and pulmonary embolism: Not a coin¬cidence. Eur J Case Rep Intern Med [Internet]. 2020 [citado: 2022 mar. 8];7(6):001692. Disponible en: https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC7279901/

Bikdeli B, Madhavan MV, Jiménez D, Chuich T, Dreyfus I, Driggin E, et al. COVID-19 and thrombotic or thromboembolic disease: Implications for prevention, antithrombotic therapy, and follow-up: JACC state-of-the-art review. J Am Coll Cardiol [Internet]. 2020 [citado: 2022 mar. 8];75(23):2950-73. Disponible en: https://pubmed.ncbi.nlm.nih.gov/32311448/

Klok FA, Kruip MJHA, van der Meer NJM, Arbous MS, Gommers DAMPJ, Kant KM, et al. Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res [Internet]. 2020 [citado: 2022 mar. 8];191:145-7. Disponible en: https://pubmed.ncbi.nlm.nih.gov/32291094/

Goeijenbier M, van Wissen M, van de Weg C, Jong E, Gerdes VEA, Meijers JCM, et al. Review: Viral infections and mechanisms of thrombosis and bleeding. J Med Virol [Internet]. 2012 [citado: 2022 mar. 8];84(10):1680-96. Disponible en: https://pubmed.ncbi.nlm.nih.gov/22930518/

Gralinski LE, Sheahan TP, Morrison TE, Menachery VD, Jensen K, Leist SR, et al. Complement activation contributes to severe acute respiratory syndrome Coronavirus pathogenesis. MBio [Internet]. 2018 [citado: 2022 mar. 8];9(5). Disponible en: https://pubmed.ncbi.nlm.nih.gov/30301856/

Miesbach W, Makris M. COVID-19: Coagulopathy, risk of thrombosis, and the ra¬tionale for anticoagulation. Clin Appl Thromb Hemost [Internet]. 2020 [citado: 2022 mar. 8 8 de marzo de 2022];26:1076029620938149. Disponible en: https://pbmed.ncbi.nlm.nih.gov/32677459/

Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet [Internet]. 2020 [citado: 2022 mar. 8];395(10229):1054-62. Disponible en: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)30566-3/fulltext

Grillet F, Behr J, Calame P, Aubry S, Delabrousse E. Acute pulmonary embolism associated with COVID-19 pneumonia detected with pulmonary CT angiography. Radiology [Internet]. 2020 [citado: 2022 mar. 8];296(3):E186-8. Disponible en: https://pubmed.ncbi.nlm.nih.gov/32324103/

Léonard-Lorant I, Delabranche X, Séverac F, Helms J, Pauzet C, Collange O, et al. Acu¬te pulmonary embolism in patients with COVID-19 at CT angiography and relationship to d-dimer levels. Radiology [Internet]. 2020 [citado: 2022 mar. 8];296(3):E189-91. Disponible en: https://pubmed.ncbi.nlm.nih.gov/32324102/

Cui S, Chen S, Li X, Liu S, Wang F. Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia. J Thromb Haemost [Internet]. 2020 [citado: 2022 mar. 8];18(6):1421-4. Disponible en: https://pubmed.ncbi.nlm.nih.gov/32271988

Lim W, Meade M, Lauzier F, Zarychanski R, Mehta S, Lamontagne F, et al. Failure of anticoagulant thromboprophylaxis: risk factors in medical-surgical critically ill patients. Crit Care Med [Internet]. 2015 [citado: 2022 mar. 8];43(2):401-10. Disponible en: https://pubmed.ncbi.nlm.nih.gov/25474533/

Corrigan D, Prucnal C, Kabrhel C. Pulmonary embolism: the diagnosis, risk-stratifi¬cation, treatment and disposition of emergency department patients. Clin Exp Emerg Med [Internet]. 2016 [citado: 2022 mar. 8];3(3):117-25. Disponible en: https://pubmed.ncbi.nlm.nih.gov/27752629/

Zheng KI, Gao F, Wang X-B, Sun Q-F, Pan K-H, Wang T-Y, et al. Letter to the Editor: Obesity as a risk factor for greater severity of COVID-19 in patients with metabo¬lic associated fatty liver disease. Metabolism [Internet]. 2020 [citado: 2022 mar. 8];108(154244):154244. Disponible en: https://pubmed.ncbi.nlm.nih.gov/32320741/

Wallace A, Albadawi H, Hoang P, Fleck A, Naidu S, Knuttinen G, et al. Statins as a preventative therapy for venous thromboembolism. Cardiovasc Diagn Ther [Internet]. 2017 [citado: 2022 mar. 8];7(S3):S207-18. Disponible en: https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC5778529/

Biere-Rafi S, Hutten BA, Squizzato A, Ageno W, Souverein PC, de Boer A, et al. Statin treatment and the risk of recurrent pulmonary embolism. Eur Heart J [Internet]. 2013 [citado: 2022 mar. 8];34(24):1800-6. Disponible en: https://academic.oup.com/eurheartj/article/34/24/1800/652421

Bompard F, Monnier H, Saab I, Tordjman M, Abdoul H, Fournier L, et al. Pulmonary embolism in patients with COVID-19 pneumonia. Eur Respir J [Internet]. 2020 [citado: 2022 mar. 8];56(1):2001365. Disponible en: https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC7236820/

Published

2021-12-30

How to Cite

(1)
Suárez Poveda, T.; Lopera Valle, J. S.; Vasco Lopez, V. A. Prevalence of Pulmonary Embolism in Patients With COVID-19, April - December 2020. Rev. colomb. radiol. 2021, 32, 5634-5638.

Issue

Section

Research articles
Crossref Cited-by logo
QR Code